Provision of HBV vaccination in prison to reduce transmission | www.emcdda.europa.eu

Best practice portal main page

Summary of the evidence

Rating

Beneficial

Provision of HBV vaccination with unknown or negative serology was found in a systematic review (ECDC/EMCDDA, 2018) to be effective in:

reducing HBV transmission in prison

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option

Provision of HBV vaccination in prison

Desired outcome(s)

reduce infectious diseases

Area(s)

Harm reduction

Specific substance or pattern of use

not-drug specific

Target group(s) or setting(s)

prison

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.

Explore all resources in the Best practice portal

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

Evidence

All of the latest research and evidence on drug-related interventions.

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice